depression with semaglutide is associated a 44% decreased risk of and a 38% decreased risk of anxiety 🔗 Click the link in our bio to read the full story Semaglutide reduces effort discounting in

The stack as a combined formulation has not been studied in randomised controlled trials

Phase 2 clinical trial data published in 2023 documented dose-dependent rises in resting heart rate, raising questions about cardiac monitoring, risk stratification, and management

speculated that ghrelin resistance observed in patients with cancer cachexia may be similar to insulin resistance in patients with type 2 diabetes mellitus, which can be mitigated by treatment with high doses of insulin (91)

Most supplements to take while on GLP-1s may help negate the side effects of the drugs

R-Alpha-Lipoic-Acid Most of us know that inflammation and oxidative stress are the leading cause of chronic diseases today